COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2035

Conditions
Bardet-Biedl SyndromeAlström Syndrome
Interventions
GENETIC

Skin biopsy

"COBBALT is considered as an interventional with minor associated risks and constrains study due to the presence of skin biopsies that may not all be part of the usual medical practice. Risks are those linked to the biopsy procedure:~* risk of pain due to the procedure performed under local anaesthesia~* can leave a visible scar (about 2 x 1 cm)"

Trial Locations (1)

67098

RECRUITING

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER